- Laboratory >
- Laboratory medicine >
- Neurodegenerative disease test kit
Neurodegenerative disease test kits
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma. This product is not for use in diagnostic procedures, for ‘Research Use Only.
Fujirebio

... concordant with amyloid PET, and is able to differentiate between Alzheimer's disease and non-Alzheimer's disease neurodegenerative diseases and to predict progression ...
Fujirebio

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-42 in human plasma. This product is not for use in diagnostic procedures, for ‘Research Use Only’.
Fujirebio

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma. This product is not for use in diagnostic procedures, ...
Fujirebio

Sample volume: 0.025 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression (1-6). Details Features ...
Fujirebio

Sample volume: 0.075 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression. The discrimination ...
Fujirebio

Sample volume: 0.025 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression (1-6). Details Features ...
Fujirebio

... This assay should be used in combination with the NPTX2 CAL-RVC pack, article no. 80909 (RUO), of the corresponding lot. Test principle The INNOTEST NPTX2 is a solid-phase enzyme immunoassay in which the neuronal ...
Fujirebio

Sample volume: 0.3 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.1-5 The discrimination ...
Fujirebio

Sample volume: 0.075 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.1-5 The discrimination ...
Fujirebio

... Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd. Intended Use:This kit is used for the in vitro quantitative detection of S100β content in human serum, plasma ...

Test for 6 Apolipoprotein E (ApoE) genotypes Seeplex® ApoE ACE Genotyping is for testing of 6 Apolipoprotein E (ApoE) genotypes that are known to be associated with the risk of developing cardiovascular diseases ...

... to buy the high quality and sanitary 96 wells human il-6 elisa kit with our professional manufacturers and suppliers. We can assure of you of the high quality and competitive price of our ELISA ...
MULTI SCIENCES(LIANKE) BIOTECH, CO.,LTD.

... to buy the high quality and sanitary 96 wells human il-6 elisa kit with our professional manufacturers and suppliers. We can assure of you of the high quality and competitive price of our ELISA ...
MULTI SCIENCES(LIANKE) BIOTECH, CO.,LTD.

Result display time: 15 min
... circulatory arrest, stroke and traumatic brain injury. S100B is also associated with neurodegenerative diseases like Alzheimer's disease or other chronic neurological diseases. ...
Your suggestions for improvement:
the best suppliers
Subscribe to our newsletter
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining